Immune Suppressive Treatment in Paediatric Myocarditis: Still Awaiting the Evidence

Overview

Journal Heart

Date 2004 Sep 16

PMID 15367496

Citations 8

Authors

M Burch

Affiliations

Soon will be listed here.

Citing Articles

Immunosuppressive Treatment for Myocarditis in the Pediatric Population: A Meta-Analysis.

He B, Li X, Li D Front Pediatr. 2019; 7:430.

PMID: 31803693 PMC: 6873897. DOI: 10.3389/fped.2019.00430.

The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature.

Bejiqi R, Retkoceri R, Maloku A, Mustafa A, Bejiqi H, Bejiqi R Open Access Maced J Med Sci. 2019; 7(1):162-173.

PMID: 30740183 PMC: 6352488. DOI: 10.3889/oamjms.2019.010.

In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy.

Lin M, Tseng Y, Chen M, Chung C, Tsai M, Wang P BMC Cardiovasc Disord. 2019; 19(1):10.

PMID: 30626332 PMC: 6325679. DOI: 10.1186/s12872-018-0981-3.

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure.

Teixeira Farinha I, Miranda J J Cardiovasc Dev Dis. 2018; 3(4).

PMID: 29367574 PMC: 5715726. DOI: 10.3390/jcdd3040031.

Acute myocarditis in children: current concepts and management.

Vashist S, Singh G Curr Treat Options Cardiovasc Med. 2009; 11(5):383-91.

PMID: 19846036 DOI: 10.1007/s11936-009-0039-z.

References

Ahdoot J, Galindo A, Alejos J, George B, BURCH C, Marelli D . Use of OKT3 for acute myocarditis in infants and children. J Heart Lung Transplant. 2000; 19(11):1118-21. DOI: 10.1016/s1053-2498(00)00179-0. View

Griffin M, Hernandez A, Martin T, GOLDRING D, Bolman R, Spray T . Dilated cardiomyopathy in infants and children. J Am Coll Cardiol. 1988; 11(1):139-44. DOI: 10.1016/0735-1097(88)90179-9. View

Liu P, Mason J . Advances in the understanding of myocarditis. Circulation. 2001; 104(9):1076-82. DOI: 10.1161/hc3401.095198. View

Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A . Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation. 2003; 107(6):857-63. DOI: 10.1161/01.cir.0000048147.15962.31. View

Kuhl U, Pauschinger M, Schwimmbeck P, Seeberg B, Lober C, Noutsias M . Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003; 107(22):2793-8. DOI: 10.1161/01.CIR.0000072766.67150.51. View

McMahon A, Van Doorn C, Burch M, Whitmore P, Neligan S, Rees P . Improved early outcome for end-stage dilated cardiomyopathy in children. J Thorac Cardiovasc Surg. 2003; 126(6):1781-7. DOI: 10.1016/j.jtcvs.2003.07.029. View

Gagliardi M, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Diomedi Camassei F . Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart. 2004; 90(10):1167-71. PMC: 1768474. DOI: 10.1136/hrt.2003.026641. View

Shirali G, Ni J, Chinnock R, Johnston J, Rosenthal G, Bowles N . Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med. 2001; 344(20):1498-503. DOI: 10.1056/NEJM200105173442002. View

Chan K, Iwahara M, Benson L, Wilson G, Freedom R . Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol. 1991; 17(2):458-60. DOI: 10.1016/s0735-1097(10)80115-9. View

10.

Gagliardi M, Bevilacqua M, Squitieri C, Boldrini R, Di Julio D, Marcelletti C . Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant. 1993; 12(6 Pt 2):S224-9. View

11.

Ciszewski A, Bilinska Z, Lubiszewska B, Ksiezycka E, Poplawska W, Michalak E . Dilated cardiomyopathy in children: clinical course and prognosis. Pediatr Cardiol. 1994; 15(3):121-6. DOI: 10.1007/BF00796323. View

12.

Burch M, Siddiqi S, Celermajer D, Scott C, Bull C, Deanfield J . Dilated cardiomyopathy in children: determinants of outcome. Br Heart J. 1994; 72(3):246-50. PMC: 1025510. DOI: 10.1136/hrt.72.3.246. View

13.

Balaji S, WILES H, Sens M, Gillette P . Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm. Br Heart J. 1994; 72(4):354-9. PMC: 1025546. DOI: 10.1136/hrt.72.4.354. View

14.

Ino T, Okubo M, Akimoto K, Nishimoto K, YABUTA K, Kawai S . Corticosteroid therapy for ventricular tachycardia in children with silent lymphocytic myocarditis. J Pediatr. 1995; 126(2):304-8. DOI: 10.1016/s0022-3476(95)70567-8. View

15.

Camargo P, SNITCOWSKY R, Luz P, Mazzieri R, Higuchi M, Rati M . Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol. 1995; 16(2):61-8. DOI: 10.1007/BF00796819. View

16.

Mason J, OConnell J, Herskowitz A, Rose N, McManus B, Billingham M . A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995; 333(5):269-75. DOI: 10.1056/NEJM199508033330501. View

17.

Maisch B, Herzum M, HUFNAGEL G, Bethge C, Schonian U . Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J. 1995; 16 Suppl O:153-61. DOI: 10.1093/eurheartj/16.suppl_o.153. View

18.

Maisch B, HUFNAGEL G, Schonian U, Hengstenberg C . The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). Eur Heart J. 1995; 16 Suppl O:173-5. DOI: 10.1093/eurheartj/16.suppl_o.173. View

19.

Cooper Jr L, Berry G, Shabetai R . Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med. 1997; 336(26):1860-6. DOI: 10.1056/NEJM199706263362603. View

20.

Kleinert S, Weintraub R, Wilkinson J, Chow C . Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant. 1998; 16(12):1248-54. View